Saibene Alberto Maria, Pipolo Carlotta, Maccari Alberto, Lozza Paolo, Chiapasco Matteo, Scotti Alberto, Borloni Roberto, Felisati Giovanni
*Resident, Otolaryngology Department, San Paolo Hospital, Università degli Studi di Milano, Milan, Italy.†Assistant Professor, Otolaryngology Department, San Paolo Hospital, Department of Health Sciences, Università degli Studi di Milano, Milan, Italy.‡Vice-Head, Otolaryngology Department, San Paolo Hospital, Milan, Italy.§Staff Doctor, Otolaryngology Department, San Paolo Hospital, Milan, Italy.¶Head, Unit of Oral Surgery, San Paolo Hospital, Department of Health Sciences, Università degli Studi di Milano, Milan, Italy.‖Head, Otolaryngology Department, San Paolo Hospital, Department of Health Sciences, Università degli Studi di Milano, Milan, Italy.
Implant Dent. 2016 Oct;25(5):698-702. doi: 10.1097/ID.0000000000000477.
Sinonasal anatomical anomalies and inflammatory conditions may reduce success rates of maxillary sinus elevation (MSE) procedures used to allow implant placement in the atrophic posterior maxilla. Approaches combining endoscopic sinus surgery (ESS) and MSE were firstly proposed by our group and have already been described in the literature. This article aims to re-evaluate the procedure in a larger sample of patients comparing results and indications with the pertaining literature.
Thirty-three patients (19 men and 14 women, mean age 52.79 ± 11.95 years) underwent combined ESS/MSE with 48 MSE procedures performed.
No intraoperative complications were reported. An uneventful and complete graft integration was obtained after 6 months in all but one patient. All patients completed prosthetic rehabilitation within 9 to 12 months.
Combined ESS and MSE has proven to be a safe and reliable procedure, which can be proposed to selected patients presenting with reversible sinonasal contraindications to MSE and should be no more considered an experimental procedure.
鼻窦解剖异常和炎症性疾病可能会降低用于在萎缩性上颌后牙区植入种植体的上颌窦提升术(MSE)的成功率。我们团队首次提出了将鼻内镜鼻窦手术(ESS)与MSE相结合的方法,并且已有文献对此进行了描述。本文旨在通过更大样本量的患者重新评估该手术,并将结果和适应症与相关文献进行比较。
33例患者(19例男性和14例女性,平均年龄52.79±11.95岁)接受了ESS/MSE联合手术,共进行了48次MSE手术。
未报告术中并发症。除1例患者外,所有患者在6个月后均实现了移植骨的顺利且完全整合。所有患者均在9至12个月内完成了修复治疗。
ESS与MSE联合手术已被证明是一种安全可靠的手术方法,可推荐给存在MSE可逆性鼻窦禁忌证的特定患者,不应再将其视为一种实验性手术。